Baxter International Inc (BAX) · Insider trading
What Baxter International's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$0
0 insiders
Net, 12 months
$0
bought less sold
Latest filing
2026-09-03
filings read to 2026-10-19
No director, officer or large holder of Baxter International reported buying or selling at the market price in the last two years. What they did report is below.
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
42 × shares withheld for tax42 × grant or award
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-02 | Foster JuliePresident, Front Line Care | Shares withheld for tax F | −2,098 | 25.70 | 29,164 | Form 4 |
| 2026-09-02 | Hider Andrew P.Director, President and CEO | Shares withheld for tax F | −54,276 | 25.70 | 518,447 | Form 4 |
| 2026-09-01 | Teaff JamesPresident, CCS | Shares withheld for tax F | −750 | 25.48 | 30,370 | Form 4 |
| 2026-06-02 | Teaff JamesPresident, CCS | Shares withheld for tax F | −321 | 18.68 | 31,063 | Form 4 |
| 2026-06-02 | Wallace Steven P.President, Adv. Surgery | Shares withheld for tax F | −153 | 18.68 | 70,128 | Form 4 |
| 2026-06-01 | Zielinski Anita ASVP, Interim CFO, CAO & Cntrlr | Grant or award A | +13,426 | – | 59,714 | Form 4 |
| 2026-05-05 | Ampofo William A. IIDirector | Grant or award A | +12,836 | – | 30,375 | Form 4 |
| 2026-05-05 | Craig Jeffrey ADirector | Grant or award A | +12,836 | – | 23,662 | Form 4 |
| 2026-05-05 | McDonnell Michael R.Director | Grant or award A | +12,836 | – | 14,647 | Form 4 |
| 2026-05-05 | Shafer David BrentDirector, Other | Grant or award A | +12,836 | – | 72,804 | Form 4 |
| 2026-05-05 | Morrison PatriciaDirector | Grant or award A | +12,836 | – | 42,386 | Form 4 |
| 2026-05-05 | Schlichting Nancy MDirector | Grant or award A | +12,836 | – | 34,994 | Form 4 |
| 2026-05-05 | Wendell Amy McBrideDirector | Grant or award A | +12,836 | – | 44,235 | Form 4 |
| 2026-05-05 | Wilkes David S.Director | Grant or award A | +12,836 | – | 37,076 | Form 4 |
| 2026-03-06 | Grade Joel T.EVP and CFO | Shares withheld for tax F | −8,153 | 17.69 | 271,674 | Form 4 |
| 2026-03-06 | Rasul ReazurEVP,Group Pres,Healthcare | Shares withheld for tax F | −12,674 | 17.69 | 125,557 | Form 4 |
| 2026-03-06 | Rosenbloom David S.EVP and General Counsel | Shares withheld for tax F | −6,620 | 17.69 | 138,216 | Form 4 |
| 2026-03-06 | Soriano Maria CeciliaGroup Pres., ITT & Pharma. | Shares withheld for tax F | −2,848 | 17.69 | 75,045 | Form 4 |
| 2026-03-06 | Zielinski Anita ASVP, CAO and Controller | Shares withheld for tax F | −1,932 | 17.69 | 46,281 | Form 4 |
| 2026-03-02 | Rosenbloom David S.EVP and General Counsel | Shares withheld for tax F | −1,336 | 19.69 | 144,837 | Form 4 |
| 2026-03-02 | Soriano Maria CeciliaGroup Pres., ITT & Pharma. | Shares withheld for tax F | −1,852 | 19.69 | 77,894 | Form 4 |
| 2026-03-02 | Rasul ReazurEVP,Group Pres,Healthcare | Shares withheld for tax F | −1,614 | 19.69 | 138,231 | Form 4 |
| 2026-02-27 | Zielinski Anita ASVP, CAO and Controller | Grant or award A | +30,864 | – | 48,214 | Form 4 |
| 2026-02-27 | Grade Joel T.EVP and CFO | Grant or award A | +42,735 | – | 279,828 | Form 4 |
| 2026-02-27 | Rosenbloom David S.EVP and General Counsel | Grant or award A | +26,709 | – | 146,173 | Form 4 |
| 2026-02-27 | Soriano Maria CeciliaGroup Pres., ITT & Pharma. | Grant or award A | +23,742 | – | 79,748 | Form 4 |
| 2026-02-27 | Carlisle CynthiaExecutive Vice President, CHRO | Grant or award A | +17,806 | – | 17,806 | Form 4 |
| 2026-02-27 | Carlisle CynthiaExecutive Vice President, CHRO | Grant or award A | +11,871 | – | 29,677 | Form 4 |
| 2026-02-27 | Hider Andrew P.Director, President and CEO | Grant or award A | +201,804 | – | 572,239 | Form 4 |
| 2026-02-13 | McDonnell Michael R.Director | Grant or award A | +1,811 | – | 1,811 | Form 4 |
| 2026-02-09 | Grade Joel T.EVP and CFO | Grant or award A | +30,504 | – | 246,048 | Form 4 |
| 2026-02-09 | Grade Joel T.EVP and CFO | Shares withheld for tax F | −9,144 | 21.73 | 236,904 | Form 4 |
| 2026-02-09 | Rasul ReazurEVP,Group Pres,Healthcare | Grant or award A | +18,951 | – | 145,616 | Form 4 |
| 2026-02-09 | Rasul ReazurEVP,Group Pres,Healthcare | Shares withheld for tax F | −5,770 | 21.73 | 139,846 | Form 4 |
| 2026-02-09 | Rosenbloom David S.EVP and General Counsel | Grant or award A | +17,055 | – | 124,689 | Form 4 |
| 2026-02-09 | Rosenbloom David S.EVP and General Counsel | Shares withheld for tax F | −5,225 | 21.73 | 119,464 | Form 4 |
| 2026-02-09 | Soriano Maria CeciliaGroup Pres., ITT & Pharma. | Grant or award A | +2,273 | – | 56,924 | Form 4 |
| 2026-02-09 | Soriano Maria CeciliaGroup Pres., ITT & Pharma. | Shares withheld for tax F | −918 | 21.73 | 56,006 | Form 4 |
| 2025-12-12 | Mason Jeanne KEVP, Chief HR Officer | Shares withheld for tax F | −650 | 19.15 | 199,853 | Form 4 |
| 2025-12-01 | Grade Joel T.EVP and CFO | Shares withheld for tax F | −8,288 | 19.08 | 215,151 | Form 4 |
| 2025-09-02 | Borzi James WEVP,Chief Supply Chain Officer | Shares withheld for tax F | −1,848 | 24.17 | 71,948 | Form 4 |
| 2025-09-02 | Grade Joel T.EVP and CFO | Grant or award A | +102,712 | – | 222,560 | Form 4 |
| 2025-09-02 | Hider Andrew P.Director, President and CEO | Grant or award A | +236,237 | – | 236,237 | Form 4 |
| 2025-09-02 | Hider Andrew P.Director, President and CEO | Grant or award A | +131,813 | – | 368,050 | Form 4 |
| 2025-09-02 | Sonig AlokEVP,Group President,Pharma | Shares withheld for tax F | −3,191 | 24.17 | 128,219 | Form 4 |
| 2025-08-19 | Shafer David BrentDirector, Other | Shares withheld for tax F | −31,337 | 24.33 | 59,446 | Form 4 |
| 2025-06-02 | Rosenbloom David S.EVP and General Counsel | Shares withheld for tax F | −16,548 | 29.55 | 106,327 | Form 4 |
| 2025-05-06 | Ampofo William A. IIDirector | Grant or award A | +7,183 | – | 17,299 | Form 4 |
| 2025-05-06 | Morrison PatriciaDirector | Grant or award A | +7,183 | – | 29,137 | Form 4 |
| 2025-05-06 | Oesterle Stephen N.Director | Grant or award A | +7,183 | – | 35,847 | Form 4 |
| 2025-05-06 | Rusckowski Stephen HDirector | Grant or award A | +7,183 | – | 16,499 | Form 4 |
| 2025-05-06 | Schlichting Nancy MDirector | Grant or award A | +7,183 | – | 21,850 | Form 4 |
| 2025-05-06 | Smith Cathy RDirector | Grant or award A | +7,183 | – | 30,345 | Form 4 |
| 2025-05-06 | Wendell Amy McBrideDirector | Grant or award A | +7,183 | – | 31,222 | Form 4 |
| 2025-05-06 | Wilkes David S.Director | Grant or award A | +7,183 | – | 23,906 | Form 4 |
| 2025-05-06 | Craig Jeffrey ADirector | Grant or award A | +7,183 | – | 10,672 | Form 4 |
| 2025-03-06 | Borzi James WEVP,Chief Supply Chain Officer | Shares withheld for tax F | −3,262 | 35.44 | 63,145 | Form 4 |
| 2025-03-06 | Borzi James WEVP,Chief Supply Chain Officer | Grant or award A | +9,989 | – | 73,134 | Form 4 |
| 2025-03-06 | Grade Joel T.EVP and CFO | Shares withheld for tax F | −4,306 | 35.44 | 88,896 | Form 4 |
| 2025-03-06 | Grade Joel T.EVP and CFO | Grant or award A | +29,538 | – | 118,434 | Form 4 |
| 2025-03-06 | Knight HeatherEVP, Chief Operating Officer | Shares withheld for tax F | −13,634 | 35.44 | 141,688 | Form 4 |
| 2025-03-06 | Knight HeatherEVP, Chief Operating Officer | Grant or award A | +35,674 | – | 177,362 | Form 4 |
| 2025-03-06 | Mason Jeanne KEVP, Chief HR Officer | Shares withheld for tax F | −4,375 | 35.44 | 183,963 | Form 4 |
| 2025-03-06 | Mason Jeanne KEVP, Chief HR Officer | Grant or award A | +15,696 | – | 199,659 | Form 4 |
| 2025-03-06 | Rasul ReazurEVP,Group Pres,Healthcare | Shares withheld for tax F | −9,341 | 35.44 | 98,394 | Form 4 |
| 2025-03-06 | Rasul ReazurEVP,Group Pres,Healthcare | Grant or award A | +26,220 | – | 124,614 | Form 4 |
| 2025-03-06 | Rosenbloom David S.EVP and General Counsel | Shares withheld for tax F | −4,922 | 35.44 | 104,780 | Form 4 |
| 2025-03-06 | Rosenbloom David S.EVP and General Counsel | Grant or award A | +17,658 | – | 122,438 | Form 4 |
| 2025-03-06 | Sonig AlokEVP,Group President,Pharma | Shares withheld for tax F | −10,839 | 35.44 | 100,332 | Form 4 |
| 2025-03-06 | Sonig AlokEVP,Group President,Pharma | Grant or award A | +29,966 | – | 130,298 | Form 4 |
| 2025-03-06 | Zielinski Anita ASVP, CAO and Controller | Grant or award A | +17,123 | – | 17,123 | Form 4 |
| 2025-03-03 | Borzi James WEVP,Chief Suppy Chain Officer | Shares withheld for tax F | −1,339 | 34.86 | 66,407 | Form 4 |
| 2025-03-03 | Knight HeatherEVP, Chief Operating Officer | Shares withheld for tax F | −3,344 | 34.86 | 155,323 | Form 4 |
| 2025-03-03 | Mason Jeanne KEVP, Chief HR Officer | Shares withheld for tax F | −1,479 | 34.86 | 188,339 | Form 4 |
| 2025-03-03 | Rasul ReazurEVP,Group Pres,Healthcare | Shares withheld for tax F | −1,987 | 34.86 | 107,735 | Form 4 |
| 2025-03-03 | Rosenbloom David S.EVP and General Counsel | Shares withheld for tax F | −1,312 | 34.86 | 109,703 | Form 4 |
| 2025-03-03 | Sonig AlokEVP,Group President,Pharma | Shares withheld for tax F | −1,936 | 34.86 | 111,171 | Form 4 |
| 2025-02-05 | Shafer David BrentDirector, Interim CEO and Chair | Grant or award A | +76,289 | – | 89,841 | Form 4 |
| 2025-01-31 | Toth Christopher A.EVP, Group Pres, Kidney Care | Shares withheld for tax F | −25,372 | 32.56 | 105,186 | Form 4 |
| 2024-12-31 | Toth Christopher A.EVP,Group Pres, Kidney Care | Shares withheld for tax F | −32,610 | 29.16 | 183,876 | Form 4 |
| 2024-12-13 | Almeida Jose eChairman, CEO, President | Shares withheld for tax F | −5,966 | 30.32 | 243,589 | Form 4 |
| 2024-12-02 | Grade Joel T.EVP and CFO | Shares withheld for tax F | −6,612 | 33.55 | 92,457 | Form 4 |
| 2024-12-02 | Knight HeatherEVP, Group Pres, Med Products | Shares withheld for tax F | −6,041 | 33.55 | 157,674 | Form 4 |
| 2024-12-02 | Rasul ReazurEVP,Group Pres,Healthcare | Shares withheld for tax F | −2,032 | 33.55 | 109,116 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.